---
schema_version: "secwatch.filing_event.v1"
accession: "0001159036-23-000017"
form_type: "8-K"
ticker: "HALO"
cik: "0001159036"
company_name: "HALOZYME THERAPEUTICS, INC."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:14:24.331248+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Halozyme discloses minimal SVB exposure; deposits insured, custodial accounts at separate banks

## Summary
- Cash deposit at SVB under $250,000 FDIC limit as of March 10, 2023.
- Majority of cash and investments held in custodial accounts at independent institutions; SVB is agent only.
- SVB is a lender on $575M credit facility with $39M commitment; no current draws and no plans to draw.
- Treasury/Fed/FDIC joint statement ensures all depositors are fully protected; money available March 13.

## SEC filing metadata
- accession: 0001159036-23-000017
- form_type: 8-K
- ticker: HALO
- cik: 0001159036
- company_name: HALOZYME THERAPEUTICS, INC.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1159036/000115903623000017/0001159036-23-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1159036/000115903623000017/halo-20230310.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001159036-23-000017
- JSON: https://secwatch.observer/filing/0001159036-23-000017.json
- Plain text: https://secwatch.observer/filing/0001159036-23-000017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.